Detalles de la búsqueda
1.
Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer.
Eur J Nucl Med Mol Imaging
; 49(11): 3878-3891, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35562529
2.
Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors.
Invest New Drugs
; 38(1): 160-171, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31402427
3.
Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer.
BMC Cancer
; 19(1): 305, 2019 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30943943
4.
Chemoradiation Therapy Followed by Surgery in the Treatment of Locoregionally Advanced Non-Small Cell Lung Cancer.
Thorac Cardiovasc Surg
; 66(2): 129-134, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28992652
5.
Correction to: Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors.
Invest New Drugs
; 39(1): 287-292, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32500464
6.
Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy.
J Immunother Cancer
; 12(4)2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649279
7.
[Setting up a department of molecular pathology in oncology in a pathology laboratory (LPCE, CHU de Nice)]. / Mise en place d'un secteur de pathologie moléculaire en oncologie au sein d'un laboratoire d'anatomie pathologique (LPCE, CHU de Nice).
Ann Pathol
; 33(1): 24-37, 2013 Feb.
Artículo
en Francés
| MEDLINE | ID: mdl-23472893
8.
Safety and efficacy of two-drug combination in elderly patients with locally advanced non-small cell lung cancer and validation of the Charlson Index as a predictor of survival.
J Thorac Dis
; 15(7): 3764-3775, 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37559621
9.
Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer.
Radiat Oncol
; 18(1): 97, 2023 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37287020
10.
Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study.
Lung Cancer
; 185: 107379, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37757576
11.
Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images.
Cancers (Basel)
; 14(7)2022 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35406511
12.
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 Trial.
J Clin Oncol
; 40(7): 719-728, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35073148
13.
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort.
Eur J Cancer
; 166: 51-59, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35278825
14.
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial.
Clin Cancer Res
; 28(18): 4018-4026, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35802649
15.
Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System.
Front Pharmacol
; 12: 657743, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33935776
16.
A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes.
Target Oncol
; 16(6): 801-811, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34661827
17.
First-Line Afatinib plus Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung Study.
Clin Cancer Res
; 27(15): 4168-4176, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34031056
18.
Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab.
Bull Cancer
; 107(9): 946-958, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646604
19.
Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study.
J Immunother Cancer
; 8(2)2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32709713
20.
Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial.
Eur J Cancer
; 138: 193-201, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32898792